𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mucopolysaccharidosis IVA (Morquio A): Identification of novel common mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene in Italian patients

✍ Scribed by Shunji Tomatsu; Mirella Filocamo; Koji O. Orii; William S. Sly; Monica A. Gutierrez; Tatsuo Nishioka; Olga Peña Serrato; Paola Di Natale; Adriana Maria Montaño; Seiji Yamaguchi; Naomi Kondo; Tadao Orii; Akihiko Noguchi


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
249 KB
Volume
24
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis


Communicated by


📜 SIMILAR VOLUMES


Molecular analysis of Turkish mucopolysa
✍ Mugen Terzioglu; Aysegul Tokatli; Turgay Coskun; Serap Emre 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB 👁 2 views

Mucopolysaccharidosis IVA (MPS IVA) is a lysosomal storage disorder caused by the deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS; EC 3.1.6.4). The deficiency of N-acetylgalactosamine-6-sulfate sulfatase leads to lysosomal accumulation of undegraded glycosaminoglycans, keratan sulfate

Identification of 31 novel mutations in
✍ Susanna Bunge; Wim J. Kleijer; Anna Tylki-Szymanska; Cordula Steglich; Michael B 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views

Mutation analysis of the N-acetylgalactosamine-6-sulfate sulfatase gene was performed in a group of 35 patients with mucopolysaccharidosis type IVA from 33 families, mainly of European origin. By nonradioactive SSCP screening, 35 different gene mutations were identified, 31 of them novel. Together t

Molecular analysis of 30 mucopolysacchar
✍ N. Venturi; A. Rovelli; R. Parini; F. Menni; F. Brambillasca; F. Bertagnolio; G. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 1 views

Mucopolysaccharidosis type I (MPS-I orMPS1) is an autosomal recessive condition characterized by a broad range of clinical symptoms. Molecular diagnosis of MPS-I is important for analyzing genotype-phenotype correlation and for selecting patients for innovative therapies. In this study we analyzed 3